Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4376
Cue Biopharma
CUE
$140M
| $73.3K | ﹤0.01% |
2,835
+2,356
| +492% | +$69.9K |
2019 Q1
30 quarters
|
|
4377
Velocity Financial
VEL
$642M
| $73.2K | ﹤0.01% |
4,876
+1,839
| +61% | +$32.2K |
2022 Q1
18 quarters
|
|
4378
FT Vest U.S. Equity Max Buffer ETF - August
AUGM
$65.5M
| $73.1K | ﹤0.01% |
2,066
| – | – |
2025 Q4
3 quarters
|
|
4379
Holley
HLLY
$307M
| $73.1K | ﹤0.01% |
30,958
+19,385
| +168% | +$53.4K |
2022 Q1
18 quarters
|
|
4380
FinWise Bancorp
FINW
$202M
| $73K | ﹤0.01% |
6,556
+2,465
| +60% | +$33.4K |
2024 Q3
8 quarters
|
|
4381
Galectin Therapeutics
GALT
$340M
| $72.8K | ﹤0.01% |
18,773
+7,196
| +62% | +$27.8K |
2025 Q4
3 quarters
|
|
4382
Innovator Equity Dual Directional 15 Buffer ETF - November
DDFN
$77M
| $72.7K | ﹤0.01% |
3,545
-3,871
| -52% | -$78.6K |
2026 Q2
1 quarter
|
|
4383
CALL
Align Technology
ALGN
$12B
| $72.7K | ﹤0.01% |
500
| – | – |
2026 Q1
2 quarters
|
|
4384
51Talk Online Education Group
COE
$67.5M
| $72.6K | ﹤0.01% |
6,308
| – | – |
2025 Q2
5 quarters
|
|
4385
Chegg
CHGG
$70.7M
| $72.6K | ﹤0.01% |
99,989
+1,254
| +1% | +$1.06K |
2016 Q2
41 quarters
|
|
4386
Asure Software
ASUR
$311M
| $72.2K | ﹤0.01% |
9,534
+5,783
| +154% | +$48.3K |
2023 Q1
14 quarters
|
|
4387
Z Squared Inc
ZSQR
$140M
| $72.2K | ﹤0.01% |
17,347
+8,201
| +90% | +$37.7K |
2022 Q4
15 quarters
|
|
4388
Sidus Space
SIDU
$123M
| $71.9K | ﹤0.01% |
39,730
+551
| +1% | +$1.18K |
2026 Q1
2 quarters
|
|
4389
RCM Technologies
RCMT
$250M
| $71.4K | ﹤0.01% |
1,756
+1,138
| +184% | +$39.3K |
2024 Q3
8 quarters
|
|
4390
Mesoblast
MESO
$1.79B
| $71.2K | ﹤0.01% |
4,863
+1,821
| +60% | +$28.9K |
2024 Q4
7 quarters
|
|
4391
ECB Bancorp
ECBK
$181M
| $71.1K | ﹤0.01% |
3,506
+2,073
| +145% | +$42.6K |
2024 Q3
8 quarters
|
|
4392
FT Vest US Equity Moderate Buffer ETF December
GDEC
$427M
| $71K | ﹤0.01% |
1,740
| – | – |
2026 Q2
1 quarter
|
|
|
FRBT
4393
Forbright Inc
FRBT
$971M
| $70.9K | ﹤0.01% |
+4,162
| New | +$78.7K |
2026 Q3
0 quarters
|
|
4394
FT Vest US Equity Deep Buffer ETF March
DMAR
$473M
| $70.6K | ﹤0.01% |
1,544
| – | – |
2025 Q2
5 quarters
|
|
4395
KinderCare Learning Companies
KLC
$251M
| $70.3K | ﹤0.01% |
37,815
+33,359
| +749% | +$124K |
2024 Q4
7 quarters
|
|
4396
Turtle Beach Corp
TBCH
$306M
| $70K | ﹤0.01% |
5,484
+3,544
| +183% | +$44.9K |
2020 Q2
25 quarters
|
|
4397
GBank Financial Holdings
GBFH
$221M
| $69.5K | ﹤0.01% |
3,825
+1,097
| +40% | +$25.8K |
2025 Q2
5 quarters
|
|
4398
SAB Biotherapeutics
SABS
$277M
| $69.5K | ﹤0.01% |
21,924
-13,978
| -39% | -$50.8K |
2026 Q1
2 quarters
|
|
4399
Brady Corp
BRC
$3.72B
| $69.4K | ﹤0.01% |
831
+95
| +13% | +$8.65K |
2016 Q1
42 quarters
|
|
4400
Vuzix
VUZI
$174M
| $69.3K | ﹤0.01% |
24,845
-26,772
| -52% | -$69.5K |
2021 Q1
22 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.